# Is the 3D-PANC MSP Model Superior to CT for Assessing Response to Neoadjuvant Treatment in PCA Patients?

> **NCT06582342** · — · RECRUITING · sponsor: **Fundación para la Investigación del Hospital Clínico de Valencia** · enrollment: 70 (estimated)

## Conditions studied

- Adenocarcinoma of the Pancreas

## Interventions

- **PROCEDURE:** Three dimensional imaging technology (3D-PANC MSP model)
- **PROCEDURE:** Computerized tomography group (conventional CT)

## Key facts

- **NCT ID:** NCT06582342
- **Lead sponsor:** Fundación para la Investigación del Hospital Clínico de Valencia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-21
- **Primary completion:** 2025-12-21
- **Final completion:** 2025-12-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06582342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06582342, "Is the 3D-PANC MSP Model Superior to CT for Assessing Response to Neoadjuvant Treatment in PCA Patients?". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06582342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*